GLOBAL ALGINATE DRESSING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Alginate Dressing Market, By Type (Antimicrobial, Non-antimicrobial), By Application (Acute Wounds, Chronic Wounds), By End User (Hospitals, Specialty Clinics, Home Healthcare, Others), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Key Developments

Product Launch/ Approvals

In April 27, 2023, 3M, a technology and science company, Health Care's innovative 3M Veraflo Therapy, with both 3M Veraflo cleanse choice complete dressing and 3M V.A.C. Veraflo cleanse choice dressing (a sliver alginate dressing), received the first-ever Food and Drug Administration (FDA) clearance for hydromechanical removal of infectious materials, non-viable tissue and wound debris which reduces the number of surgical debridement’s required.
In October 2022, Healthium Medtech, a global medical devices company focused on surgical, post-surgical and chronic care, launched a new wound dressing portfolio Theruptor Novo for the management of chronic wounds like diabetic foot ulcers and leg ulcers.
In February 2022, the silver alginate dressing manufactured by Winner Medical, a medical device company, has been granted U.S. FDA market access (510K Number: K202982), and the company will continue to expand its operations in North America.

Figure 2. Global Alginate Dressing Market Share (%), By End User, 2023